Anavex Life Sciences Corp (AVXL)

[crescentmotor]

The pediatric Rett syndrome EXCELLENCE trial using Anavex's blarcamesine was NOT a failure.

Great!!! When is the expected commercialization date when revenues start to pour through the door, Georgie? The FACT is the trial failed to meet multiple prescribed endpoints per the AVXL press release and the stock price declined significantly upon the release of the trial results. But, by all means, you continue to be you--a shameless pumper.